Screening Study to Identify Patients With Complement Factor I Deficiencies

Stopped early

Conditions studied: Previous Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I Deficiency

In brief

This is screening study to identify patients with Complement Factor I deficiencies. The primary objective is to identify participants with CFI deficiencies and assess the prevalence in the screened population.

Key facts

Study ID

NCT05072912

Run by

Catalyst Biosciences

People needed

113

Starts

2021-07-21

Expected to finish

2021-11-23

Last updated by the study team

2022-04-08

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• An individual must meet all the following criteria to be eligible to participate in this study:
• A male or female ≥6 months of age who has been diagnosed with a complement-mediated disease in which a reasonable etiological association with CFI deficiency has been reported
• Affirmation of participant's informed consent or LAR's willingness to provide informed consent with signature confirmation before any study-related activities. (Study-related activities are any procedures that would not have been performed during normal clinical management of the participant.) The participant (if a minor) must be willing to give written informed assent if the minor is within the age groups 7 to 11 years old and 12 to 17 years old.

You may not qualify if…

• Diagnosis of age-related macular degeneration that is complement-related with no concurrent systemic complement involvement

Where it is running

• Nephrology Consultants, LLC — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.